In 2019, The Center for Psychedelic and Consciousness Research was founded at Johns Hopkins School of Medicine.

The Center will focus on how psychedelics (such as psilocybin) affect behavior, brain function, learning and memory, the brain's biology, and mood. Since 2006, the researchers have published studies in more than 60 peer-reviewed journal articles. Their research has demonstrated therapeutic benefits of psychedelics for people who suffer from conditions including nicotine addiction and depression and anxiety caused by life-threatening diseases such as cancer. This promising research has paved the way for current studies on treatment of major depressive disorder. https://hub.jhu.edu/2019/09/04/hopkins-launches-psychedelic-center

Sign up for the Center’s newsletter at: hopkinspsychedelic.org